Quantcast

Posts related to ‘LLY’

24/7 Wall St. Closing Bell — October 23, 2012: Markets Follow Earnings Lower (BTU, BHI, P, YHOO, MNST, CE, WDC, TXN, MMM, ARMH, AKS, COH, HOG, RSH, UPS, UTX, XRX, AMGN, BRCM, FB, JNPR, NFLX, T, BA, GLW, DAL, LLY, EMC, GD, LCC, DD, BSDM)

The three major U.S. stock indexes opened lower this morning and remained in negative territory all day. The decline is down to weak earnings from many U.S. firms reporting results ...
Read Full Story »

Top Analyst Upgrades and Downgrades (AAPL, BIDU, DTV, LLY, EPD, EVER, FB, ITW, JNJ, INTC, IPG, LAZ, NFLX, OPTR, PIR, RSH, TSM, VRTX)

These are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday. Apple Inc. (NASDAQ: AAPL) reiterated Outperform with $750 target at Credit ...
Read Full Story »

Lilly Adds $1 Billion in Market Value from Alzheimer’s Study Data

Eli Lilly & Co. (NYSE: LLY) is confirming prior news showing that late-stage trial data analysis showed the the primary endpoints in cognitive and functional were not met in the two ...
Read Full Story »

Top Analyst Upgrades and Downgrades (ATVI, ADTN, AMD, AOL, CHK, CLF, CVGI, EA, LLY, FB, FDX, GRPN, HES, LNKD, OSIS, GOLD, RIO, STM, TWX, TIVO, WAB, ZNGA)

These are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Wednesday. Activision Blizzard Inc. (NASDAQ: ATVI) started as Buy at Jefferies. Adtran Inc. ...
Read Full Story »

24/7 Wall St. Closing Bell — August 27, 2012: Markets Lack Enthusiasm, Close Mixed (AMZN, BRCD, LLY, ADSK, THS, TIF, SDRL, STP, BWS, MY, MOV, SFM, HCBK, MTB, KNXA, IBM, PANL, AAPL)

The three major U.S. stock indexes opened flat to higher this morning but picked up some buying steam after the first hour or so of trading. In Europe the president ...
Read Full Story »

Top Analyst Upgrades and Downgrades (AMZN, BNNY, ADSK, BBY, BMRN, BRCD, LLY, FNF, GTIV, THS)

These are the top analyst calls of upgrades, downgrades and initiations we have seen from Wall St. research calls this Monday morning. Amazon.com Inc. (NASDAQ: AMZN) reiterated Buy with $264 ...
Read Full Story »

Alzheimer’s Drug Shows Some Success (LLY, PFE, ELN)

Drugmaker Eli Lilly & Co. (NYSE: LLY) announced this morning that the company’s solanezumab treatment for Alzheimer’s disease failed to meet both the cognitive and functional endpoints in recently completed ...
Read Full Story »

Top Analyst Upgrades and Downgrades (NLY, CSH, CIEN, CRUS, DE, LLY, FSLR, JPM, HP, PETM, PSX, PHM, SNDK)

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall St. research calls this Monday morning. Annaly Capital Management Inc. (NYSE: NLY) cut to Underperform at Wells ...
Read Full Story »

24/7 Wall St. Closing Bell — July 25, 2012: Markets Mixed on Spotty Earnings Reports

The three major US stock indexes opened mixed this morning with the Nasdaq Composite slightly negative on an unexpectedly weak earnings report from Apple Inc. (NASDAQ: AAPL) (more coverage here). ...
Read Full Story »

Drug Giants Show Mixed Earnings (BMY, LLY)

Surging growth of its Cymbalta depression treatment helped Eli Lilly & Co. (NYSE: LLY) beat Wall St.'s earnings expectations. But generic rivals to Plavix, other drugs hurt Bristol-Myers Squibb Co. ...
Read Full Story »

24/7 Wall St. Closing Bell — July 24, 2012: Markets Fall on Weak Quarterly Results

The three major US stock indexes opened roughly flat this morning as Spanish 10-year bond yields rose to 7.5% and Moody’s cut Germany’s outlook to ‘negative’ after the markets closed ...
Read Full Story »

Pfizer’s Alzheimer’s Drug Fails Trial

A new treatment for Alzheimer's disease from Pfizer Inc. (NYSE: PFE) and partner Elan Corp. plc (NYSE: ELN) has failed a late-stage trial in patients with mild-to-moderate cases of the ...
Read Full Story »

Top 10 U.S. Drugs for 2012 First Quarter

Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for the first quarter of 2012. The top five sellers include ...
Read Full Story »

Abbott Labs Stung by Foreign Exchange Rate

Abbott Laboratories (NYSE: ABT) reported second-quarter results this morning that beat the consensus estimate for earnings per share (EPS), but missed slightly on revenues. The drug maker reported adjusted diluted ...
Read Full Story »

GlobeImmune Files For IPO, Cancer & Hepatitis with Great Partnerships

GlobeImmune, Inc. is the latest biotech to file for an initial public offering.  Financial terms were not disclosed but the first filing is for up to $69 million in common ...
Read Full Story »